BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 21232998)

  • 1. Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.
    Neishabury M; Azarkeivan A; Oberkanins C; Abedini SS; Zamani S; Najmabadi H
    Blood Cells Mol Dis; 2011 Mar; 46(3):201-5. PubMed ID: 21232998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4.
    Neishabury M; Zamani S; Azarkeivan A; Abedini SS; Darvish H; Zamani F; Najmabadi H
    Blood Cells Mol Dis; 2012 Jan; 48(1):1-5. PubMed ID: 22036762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
    Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
    Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of thalassemia intermedia in Iran.
    Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
    Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of an α-Globin Gene Triplication with β-Globin Gene Mutations in Iranian Patients with β-Thalassemia Intermedia.
    Farashi S; Bayat N; Faramarzi Garous N; Ashki M; Montajabi Niat M; Vakili S; Imanian H; Zeinali S; Najmabadi H; Azarkeivan A
    Hemoglobin; 2015; 39(3):201-6. PubMed ID: 26084319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mouse beta-globin locus control region: hypersensitive sites 3 and 4.
    Jiménez G; Gale KB; Enver T
    Nucleic Acids Res; 1992 Nov; 20(21):5797-803. PubMed ID: 1454540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms underlying thalassemia intermedia in Iran.
    Neishabury M; Azarkeivan A; Oberkanins C; Esteghamat F; Amirizadeh N; Najmabadi H
    Genet Test; 2008 Dec; 12(4):549-56. PubMed ID: 18939939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of β-thalassemia patients: first identification of mutations HBB:c.93-2A>G and HBB:c.114G>A in Brazil.
    Fernandes AC; Shimmoto MM; Furuzawa GK; Vicari P; Figueiredo MS
    Hemoglobin; 2011; 35(4):358-66. PubMed ID: 21797703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5'HS4 core element of the human beta-globin locus control region is required for high-level globin gene expression in definitive but not in primitive erythropoiesis.
    Navas PA; Peterson KR; Li Q; McArthur M; Stamatoyannopoulos G
    J Mol Biol; 2001 Sep; 312(1):17-26. PubMed ID: 11545582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 13-bp deletion in the 3' untranslated region of the β-globin gene causes β-thalassemia major in compound heterozygosity with IVSII-1 mutation.
    Hamid M; Akbari MT
    Med Princ Pract; 2011; 20(5):488-90. PubMed ID: 21757944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of positive XmnIGgamma polymorphism and coinheritance of common alpha thalassemia mutations do not show statistically significant difference between thalassemia major and intermedia cases with homozygous IVSII-1 mutation.
    Neishabury M; Azarkeivan A; Najmabadi H
    Blood Cells Mol Dis; 2010; 44(2):95-9. PubMed ID: 19892574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic and additive properties of the beta-globin locus control region (LCR) revealed by 5'HS3 deletion mutations: implication for LCR chromatin architecture.
    Fang X; Sun J; Xiang P; Yu M; Navas PA; Peterson KR; Stamatoyannopoulos G; Li Q
    Mol Cell Biol; 2005 Aug; 25(16):7033-41. PubMed ID: 16055715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromobility Shift Assay Reveals Evidence in Favor of Allele-Specific Binding of RUNX1 to the 5' Hypersensitive Site 4-Locus Control Region.
    Dehghani H; Ghobakhloo S; Neishabury M
    Hemoglobin; 2016 Aug; 40(4):236-9. PubMed ID: 27492765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carrier frequency of α-globin gene triplication in an Iranian population with normal or borderline hematological parameters.
    Moosavi SF; Amirian A; Zarbakhsh B; Kordafshari A; Mirzahoseini H; Zeinali S; Karimipoor M
    Hemoglobin; 2011; 35(4):323-30. PubMed ID: 21797699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.
    Kukreti R; Dash D; E VK; Chakravarty S; Das SK; De M; Talukder G
    Am J Hematol; 2002 Aug; 70(4):269-77. PubMed ID: 12210807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of beta-thalassemia mutations and beta-locus control region hypersensitive sites 2, 3 and 4 in southern Thailand.
    Sriroongrueng W; Schleiemacher E; Panich V; Nopparatana C; Saechan V; Laosombat V; Pornpatkul M; Fukumaki Y
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():120-7. PubMed ID: 9640613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients.
    Harteveld CL; Refaldi C; Cassinerio E; Cappellini MD; Giordano PC
    Blood Cells Mol Dis; 2008; 40(3):312-6. PubMed ID: 18249014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterozygous β thalassemia with triplication of the α globin gene].
    Constanço MC; Rocha P; Bento C; Silva HM
    Acta Med Port; 2011; 24(4):633-6. PubMed ID: 22521023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel mutations in the 3' untranslated region of the beta-globin gene that are associated with the mild phenotype of beta thalassemia.
    Bilgen T; Clark OA; Ozturk Z; Akif Yesilipek M; Keser I
    Int J Lab Hematol; 2013 Feb; 35(1):26-30. PubMed ID: 22862814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family.
    Haghi M; Feizi AA; Harteveld CL; Pouladi N; Feizi MA
    Hemoglobin; 2009; 33(1):75-80. PubMed ID: 19205978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.